Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2008, Vol. 35 Issue (3): 183-186    DOI:
Original Research Previous articles | Next articles
Association of Fas-670 gene polymorphism with risk of cervical cancer in North Indian population
D. M. Kordi Tamandani1, *(), R. C. Sobti1, M. Shekari1
1Department of Biotechnology, Panjab University, Chandigrah (India)
Download:  PDF(67KB)  ( 4 )
Export:  BibTeX | EndNote (RIS)      
Abstract  
Objectives: Cervical cancer is the second most common cancer among women in the world, with approximately 470,000 new cases and 231,000 deaths occurring each year. Incidence is greater in developing countries such as India, where this is the most common female malignancy with almost 100,000 new cases each year. Apoptosis must be considered as a safe mechanism that controls the integrity of the cell erasing abnormal clones and it is likely that failure of apoptosis constitutes a key factor responsible for tumor formation, progression and resistance to drugs. The Fas gene plays a key role in regulation of apoptotic cell death and corruption of this signaling pathway has been shown to participate in immune escape and tumorgenesis. Study design: A singlenucleotide polymorphism at -670 of Fas gene promoter (A/G) was examined in a total of 400 blood samples from normal healthy women and cervical cancer patients, using polymerase chain reaction and restriction fragment length polymorphism (PCR-RFLP) technique. Results: Significant association was observed for AG (OR = 3.0, 95% CI = (1.68-5.09, p < 0.001) and combined AG+GG (OR = 2.54, 95% CI = 1.47-4.40, p < 0.001) genotype with risk of cervical cancer. Heterozygous genotype (AG) in SCC showed a highly significant association with risk of cervical cancer (OR = 2.57, 95% CI = 1.47-4.50 p < 0.001). Similarly, combined AG+GG genotype had a 2.25-fold risk for SCC patients (OR = 2.25, 95% Cl = 1.30-3.90, p < 0.001). There was high increase risk of cervical cancer in passive smokers with AG and combined (AG+GG) genotypes (OR = 4.6, 95% CI = 2.07-10.32, p < 0.001 - OR = 4.9, 95% CI = 2.20-10.32, p < 0.001), respectively. Conclusion: This is the first study to provide evidence for the association of a Fas -670 (A/G) gene polymorphism with the risk of cervical cancer in a North Indian population.
Key words:  Fas gene      Polymorphism      Cervical cancer     
Published:  10 September 2008     
*Corresponding Author(s):  D. M. K. TAMANDANI     E-mail:  dor_kordi@yahoo.com

Cite this article: 

D. M. Kordi Tamandani, R. C. Sobti, M. Shekari. Association of Fas-670 gene polymorphism with risk of cervical cancer in North Indian population. Clinical and Experimental Obstetrics & Gynecology, 2008, 35(3): 183-186.

URL: 

https://ceog.imrpress.com/EN/     OR     https://ceog.imrpress.com/EN/Y2008/V35/I3/183

[1] Yi Zhou, Ran Wang, Shi-Xian Chen, Li-Sheng Wu, Jun-Qing Zhu. Matrix metalloproteinase 9 gene promoter region -1562 C/T single nucleotide polymorphism increases the susceptibility to hypertensive disorders of pregnancy: a meta-analysis[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(2): 245-252.
[2] Maliheh Arab, Atefeh Moridi, Ghazaleh Fazli, Robabeh Ghodssi-Ghasemabadi, Maryam Maktabi, Samaneh Saraeian, Mahdie Sanati. Is visual inspection with acetic acid (VIA) a useful method of finding pre-invasive cervical cancer?[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(1): 128-131.
[3] J. Wang, S.W. Chen, X.Y. Qin, X.Z. Zheng, P. Wang, X.Y. Cai. Clinical application of short tandem repeat polymorphism analysis in the differential diagnosis of early hydatidiform mole and hydropic abortion[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 490-495.
[4] N. Haya, I. Feferkorn, F. Fares, N. Azzam, R. Auslender, Y. Abramov. Elastin genetic point mutation and the risk of pelvic organ prolapse[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(1): 75-78.
[5] H.-H. Lee, M.-J. Mun, T.-H. Kim, Y.-S. Kim, W.-C. Jang, J.-Y. Hwang. Relationships between vitamin D receptor genetic polymorphisms and endometriosis in Korean women[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(6): 876-880.
[6] M. Englert-Golon, N. Smolarek, B. Burchardt, R. Słopień, S. Sajdak. A case of cervical cancer diagnosed during pregnancy[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(6): 1005-1006.
[7] F. Li, R. Yin, H. Jiang, G. Luo. Adult vaginal foreign body misdiagnosed as cervical cancer: a case report and literature review[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(3): 476-478.
[8] O.S. Kerimoglu, A. Pekin, S.A. Yılmaz, F.N. İncesu, S. Nergiz, N.U. Doğan, H. Acar, C. Celik. Effect of the FSH receptor polymorphism on the age at menarche[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(2): 241-244.
[9] A.M. Malutan, R. Ciortea, C. Porumb, R.F. Mocan-Hognogi, D. Mihu. Vascular endothelial growth factor genetic polymorphisms at +405C/G and -460 C/T and the association with advanced stages of endometriosis[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(5): 725-730.
[10] A. Jafari, S. Parchami, S. Reiisi, S. Miraj. Association of plasma homocysteine, folic acid levels, and C677T polymorphism in methylene tetra hydrofolate reductase with risk of preeclampsia: a case-control study in Iranian women[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(3): 367-374.
[11] H. Ueda, G. Minase, T. Miyamoto, M. Iijima, Y. Saijo, M. Nakashima, N. Matsumoto, M. Namiki, K. Sengoku. Single-nucleotide polymorphisms in ETV5: a risk factor for Sertoli cell-only syndrome in Japanese men?[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(2): 187-189.
[12] Y. Yang, B.R. Luo, M. Hu, D.M. Zhao, W.J. Jing. Association of CD36 gene single nucleotide polymorphism with gestational diabetes mellitus in Chinese Han population[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(2): 266-271.
[13] Guiling Wang, Aifang Jiang, Chun'e Ren. The relationship between qh+ and recurrent spontaneous abortion[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(1): 102-104.
[14] Peng Zhang, Qi-wen Wu, Gang Feng, Chun-sheng Liu, Ying-ying Zhang, Chun Pu. Protein Z and anti-protein Z IgG levels, but not the promotor A13G polymorphism, are associated with preeclampsia[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(6): 929-933.
[15] L. Liu, Y.M. Chen, Q.Y. Zhang, C.Z. Li. Roles of high-risk human papilloma virus (HR-HPV) E6/E7mRNA in triaging HPV16/18 cases[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(5): 740-743.
No Suggested Reading articles found!